Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications by Nega Berhe

38 publications found

Original articles

Alemu AS, Kempker RR, Tenna A, Smitson C, Berhe N, Fekade D, Blumberg HM, Aseffa A (2013)
High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia
PLoS One, 8 (3), e58377
DOI 10.1371/journal.pone.0058377, PubMed 23469276

Berhe N, Myrvang B, Gundersen SG (2009)
Gastro-intestinal symptoms associated with intense Schistosoma mansoni infection affect class-attentiveness of schoolchildren in Ethiopia
Acta Trop, 110 (1), 52-6
DOI 10.1016/j.actatropica.2009.01.007, PubMed 19283896

Berhe N, Myrvang B, Gundersen SG (2008)
Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia
Am J Trop Med Hyg, 78 (2), 228-34
DOI 10.4269/ajtmh.2008.78.228, PubMed 18256420

Berhe N, Myrvang B, Gundersen SG (2007)
Intensity of Schistosoma mansoni, hepatitis B, age, and sex predict levels of hepatic periportal thickening/fibrosis (PPT/F): a large-scale community-based study in Ethiopia
Am J Trop Med Hyg, 77 (6), 1079-86
DOI 10.4269/ajtmh.2007.77.1079, PubMed 18165526

Berhe N, Halvorsen BL, Gundersen TE, Myrvang B, Gundersen SG, Blomhoff R (2007)
Reduced serum concentrations of retinol and alpha-tocopherol and high concentrations of hydroperoxides are associated with community levels of S. mansoni infection and schistosomal periportal fibrosis in Ethiopian school children
Am J Trop Med Hyg, 76 (5), 943-9
DOI 10.4269/ajtmh.2007.76.943, PubMed 17488920

Berhe N, Geitung JT, Medhin G, Gundersen SG (2006)
Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia
Trop Med Int Health, 11 (8), 1286-94
DOI 10.1111/j.1365-3156.2006.01665.x, PubMed 16903891

Hailu A, van Baarle D, Knol GJ, Berhe N, Miedema F, Kager PA (2005)
T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani
Clin Immunol, 117 (2), 182-91
DOI 10.1016/j.clim.2005.06.015, PubMed 16125466

Hailu A, van der Poll T, Berhe N, Kager PA (2004)
Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis
Am J Trop Med Hyg, 71 (5), 561-7
PubMed 15569785

Gebre-Michael T, Malone JB, Balkew M, Ali A, Berhe N, Hailu A, Herzi AA (2004)
Mapping the potential distribution of Phlebotomus martini and P. orientalis (Diptera: Psychodidae), vectors of kala-azar in East Africa by use of geographic information systems
Acta Trop, 90 (1), 73-86
DOI 10.1016/j.actatropica.2003.09.021, PubMed 14739026

Berhe N, Medhin G, Erko B, Smith T, Gedamu S, Bereded D, Moore R, Habte E, Redda A, Gebre-Michael T, Gundersen SG (2004)
Variations in helminth faecal egg counts in Kato-Katz thick smears and their implications in assessing infection status with Schistosoma mansoni
Acta Trop, 92 (3), 205-12
DOI 10.1016/j.actatropica.2004.06.011, PubMed 15533288

Eidsmo L, Wolday D, Berhe N, Sabri F, Satti I, El Hassan AM, Sundar S, Chiodi F, Akuffo H (2002)
Alteration of Fas and Fas ligand expression during human visceral leishmaniasis
Clin Exp Immunol, 130 (2), 307-13
DOI 10.1046/j.1365-2249.2002.01976.x, PubMed 12390320

Wolday D, Mayaan S, Mariam ZG, Berhe N, Seboxa T, Britton S, Galai N, Landay A, Bentwich Z (2002)
Treatment of intestinal worms is associated with decreased HIV plasma viral load
J Acquir Immune Defic Syndr, 31 (1), 56-62
DOI 10.1097/00126334-200209010-00008, PubMed 12352151

Hailu A, Kroon CC, Schoone GJ, Berhe N, Schallig HD, Kager PA (2002)
Sero-epidemiological assessment and diagnosis of visceral leishmaniasis in an endemic locality using Fast Agglutination Screening Test (FAST)
Acta Trop, 83 (2), 93-101
DOI 10.1016/s0001-706x(02)00063-3, PubMed 12088850

Hailu A, Balcha F, Birrie H, Berhe N, Aga A, Mengistu G, Bezuneh A, Ali A, Gebre-Michael T, Gemetchu T (2002)
Prevalence of onchocercal skin disease and infection among workers of coffee plantation farms in Teppi, southwestern Ethiopia
Ethiop Med J, 40 (3), 259-69
PubMed 12602250

Balkew M, Gebre-Michael T, Berhe N, Ali A, Hailu A (2002)
Leishmaniasis in the middle course of the Ethiopian Rift Valley: II. Entomological observations
Ethiop Med J, 40 (3), 271-82
PubMed 12602251

Erko B, Abebe F, Berhe N, Medhin G, Gebre-Michael T, Gemetchu T, Gundersen SG (2002)
Control of Schistosoma mansoni by the soapberry Endod (Phytolacca dodecandra) in Wollo, northeastern Ethiopia: post-intervention prevalence
East Afr Med J, 79 (4), 198-201
DOI 10.4314/eamj.v79i4.8878, PubMed 12625676

Erko B, Medhin G, Berhe N, Abebe F, Gebre-Michael T, Gundersen SG (2002)
Epidemiological studies on intestinal schistosomiasis in Wondo Genet, southern Ethiopia
Ethiop Med J, 40 (1), 29-39
PubMed 12240565

Hailu A, Berhe N (2002)
The performance of direct agglutination tests (DAT) in the diagnosis of visceral leishmaniasis among Ethiopian patients with HIV co-infection
Ann Trop Med Parasitol, 96 (1), 25-30
DOI 10.1179/000349802125000475, PubMed 11989530

Berhe N, Abraham Y, Hailu A, Ali A, Mengistu G, Tsige K, Abebe Y (2001)
Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis
East Afr Med J, 78 (11), 608-10
DOI 10.4314/eamj.v78i11.8952, PubMed 12219968

Wolday D, Berhe N, Akuffo H, Desjeux P, Britton S (2001)
Emerging Leishmania/HIV co-infection in Africa
Med Microbiol Immunol, 190 (1-2), 65-7
DOI 10.1007/s004300100082, PubMed 11770113

Berhe N, Hailu A, Abraham Y, Tadesse Y, Breivik K, Abebe Y (2001)
Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study
Acta Trop, 80 (2), 87-95
DOI 10.1016/s0001-706x(01)00156-5, PubMed 11600084

Hailu A, Menon JN, Berhe N, Gedamu L, Hassard TH, Kager PA, Olobo J, Bretscher PA (2001)
Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure
J Infect Dis, 184 (1), 112-5
DOI 10.1086/320994, PubMed 11398119

Wolday D, Berhe N, Britton S, Akuffo H (2000)
HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani
AIDS, 14 (8), 921-9
DOI 10.1097/00002030-200005260-00003, PubMed 10853973

Berhe N, Wolday D, Hailu A, Abraham Y, Ali A, Gebre-Michael T, Desjeux P, Sönnerborg A, Akuffo H, Britton S (1999)
HIV viral load and response to antileishmanial chemotherapy in co-infected patients
AIDS, 13 (14), 1921-5
DOI 10.1097/00002030-199910010-00015, PubMed 10513651

Berhe N, Gundersen SG, Abebe F, Birrie H, Medhin G, Gemetchu T (1999)
Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia
Acta Trop, 72 (1), 53-63
DOI 10.1016/s0001-706x(98)00084-9, PubMed 9924961

Birrie H, Abebe F, Gundersen SG, Medhin G, Berhe N, Gemetchu T (1998)
Epidemiology of schistosomiasis mansoni in three endemic communities in north-east Ethiopia: baseline characteristics before endod based intervention
Ethiop Med J, 36 (2), 101-11
PubMed 10214452

Berhe N, Balkew M, Gebre-Michael T, Ali A, Hailu A (1998)
Leishmaniasis in the middle course of the Ethiopian Rift Valley: I. Clinical and leishmanin skin test surveys
Ethiop Med J, 36 (2), 113-22
PubMed 10214453

Hailu A, Berhe N, Ali A, Gemetchu T (1997)
Use of Leishmania major derived leishmanin for skin test surveys of visceral leishmaniasis in Ethiopia
East Afr Med J, 74 (1), 41-5
PubMed 9145577

Hailu A, Berhe N, Yeneneh H (1996)
Visceral leishmaniasis in Gambela, western Ethiopia
Ethiop Med J, 34 (1), 33-42
PubMed 8674498

Hailu A, Berhe N, Sisay Z, Abraham I, Medhin G (1996)
Seroepidemiological and leishmanin skin test surveys of visceral leishmaniasis in south and southwest Ethiopia
Ethiop Med J, 34 (1), 11-23
PubMed 8674496

Hailu A, Balkew M, Berhe N, Meredith SE, Gemetchu T (1995)
Is Phlebotomus (Larroussius) orientalis a vector of visceral leishmaniasis in south-west Ethiopia?
Acta Trop, 60 (1), 15-20
DOI 10.1016/0001-706x(95)00093-t, PubMed 8546034

Berhe N, Hailu A, Gemetchu T (1995)
Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to Leishmania aethiopica
Trans R Soc Trop Med Hyg, 89 (4), 400-1
DOI 10.1016/0035-9203(95)90027-6, PubMed 7570878

Berhe N, Hailu A, Wolday D, Negesse Y, Cenini P, Frommel D (1995)
Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus
Trans R Soc Trop Med Hyg, 89 (2), 205-7
DOI 10.1016/0035-9203(95)90497-2, PubMed 7778150

Berhe N, Ali A, Hailu A, Yeneneh H (1994)
Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation
Acta Trop, 57 (1), 83-90
DOI 10.1016/0001-706x(94)90096-5, PubMed 7942358

Review articles

Wolday D, Berhe N, Akuffo H, Britton S (1999)
Leishmania-HIV interaction: immunopathogenic mechanisms
Parasitol Today, 15 (5), 182-7
DOI 10.1016/s0169-4758(99)01431-3, PubMed 10322351

Other articles

Berhe N (1995)
Seeking an appropriate and low cost diagnostic method for intestinal schistosomiasis
Ethiop Med J, 33 (3), 193-4
PubMed 7588659

Cenini P, Berhe N, Hailu A, Frommel D (1994)
Mononuclear cell subpopulations in human immunodeficiency virus (HIV)-positive versus HIV-negative patients with visceral leishmaniasis
J Infect Dis, 169 (3), 707-8
DOI 10.1093/infdis/169.3.707, PubMed 8158062

Theses

Berhe N (2009)
Morbidity studies of schistosomiasis mansoni in Ethiopia: patterns and determinants
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 778, 1 b. (flere pag.)
BIBSYS 092576273, ISBN 978-82-8072-933-0

0.13s